Assessment of the Iran Action Plan against Antimicrobial Resistance

Shahrbano Shafian; Zahra Sharif; Leila Zarei; Mohammad Hadidi; Kamran Bagheri Lankarani

doi:10.18502/jppm.v9i1.12881

Shahrbano Shafian Health Policy Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran.
Zahra Sharif Department of Pharmacology, School of Pharmacy, Alborz University of Medical Sciences, Karaj, Iran
Leila Zarei Health Policy Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran.
Mohammad Hadidi School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran
Kamran Bagheri Lankarani Health Policy Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran

DOI: https://doi.org/10.18502/jppm.v9i1.12881

Keywords: Antimicrobial resistance, National Action Plan, Iran

Abstract

Background: The Islamic Republic of Iran provided a national action plan against antimicrobial resistance (NAP/AMR) for 2016-2021. In this study, we have dealt with the background and Iran’s efforts in this way, compare Iran’s NAP/AMR with other international programs, represent efficient policy options, and the evaluation indicators of each purpose of Iran NAP/AMR. The indicators of each group are represented through the consensus of three academic researchers. Finally, our assessment reveals that performing a constant observation is highly required for a prearranged NAP/AMR. The political parties and stakeholders should punctually receive interpretable feedbacks; also, it is very important to conduct periodical assessments with the purpose of perceiving the purpose feasibility and determining the dimensions that require advancements.